论文部分内容阅读
目的分析我国近20年肝脏炎性肌纤维母细胞瘤(IMT)流行病学特征及诊治。方法联合检索维普数据库、中国知网及中国生物医学文献数据库等数据库1993—2013年有关肝脏炎性假瘤、肝脏IMT的文献,回顾性总结分析其流行病学特征及诊治分析。结果共检索有效文献172篇计1672例患者,男女比例为1.91∶1;中位年龄41.83岁;患者临床表现无特异性;首选行肝脏核磁共振成像(MRI)检查,确诊率高;临床多采用局部切除手术治疗。结论肝脏IMT在临床上少见,其临床表现缺乏特异性,CT、MRI检查有助于诊断,而病理组织学及免疫组化对本病具有决定性的诊断价值,且局部切除术可达到根治的效果,预后良好。
Objective To analyze the epidemiological features and diagnosis and treatment of hepatic inflammatory myofibroblastic tumor (IMT) in recent 20 years in our country. Methods The databases of Vip Database, CNKI and China Biomedical Literature Database were searched from 1993 to 2013, and the literature of hepatic inflammatory pseudotumor and liver IMT were retrospectively analyzed. The epidemiological characteristics and diagnosis and treatment were analyzed retrospectively. Results A total of 172 articles with valid articles were retrieved from 1672 patients, the ratio of male to female was 1.91:1. The median age was 41.83 years old. The clinical manifestations of the patients were non-specific. The first choice was confirmed by liver magnetic resonance imaging (MRI) Local excision surgery. Conclusions Liver IMT is rare in clinical practice, and its clinical manifestations are not specific. CT and MRI can be helpful to diagnose the disease, while histopathology and immunohistochemistry have a decisive diagnostic value for this disease, and radical resection can achieve the curative effect. The prognosis is good.